Performance on complex memory tests is associated with ß-amyloid in individuals at risk of developing Alzheimer's disease

被引:2
|
作者
Kjeldsen, Pernille Louise [1 ,2 ,3 ,10 ]
Damholdt, Malene Flensborg [1 ,4 ]
Madsen, Lasse Stensvig [1 ,5 ]
Nissen, Peter Henrik [1 ,6 ]
Aanerud, Joel Fredrik Astrup [2 ]
Parbo, Peter [1 ,7 ]
Ismail, Rola [8 ]
Kaasing, Malene [1 ,5 ]
Eskildsen, Simon Fristed [1 ,5 ]
Ostergaard, Leif [1 ,5 ]
Brooks, David James [1 ,2 ,5 ,9 ]
机构
[1] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Nucl Med & PET, Aarhus, Denmark
[3] Aalborg Univ Hosp, Dept Neurol, Aalborg, Denmark
[4] Aarhus Univ, Dept Psychol, Aarhus, Denmark
[5] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark
[6] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark
[7] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[8] Sygehus Lillebaelt, Dept Nucl Med, Vejle, Denmark
[9] Univ Newcastle Tyne, Translat & Clin Res Inst, Newcastle Upon Tyne, Northumberland, England
[10] Aarhus Univ Hosp, Palle Juul Jensens Blvd 165, DK-8200 Aarhus, Denmark
基金
欧盟地平线“2020”;
关键词
amyloid imaging; APOE4; memory; neuropsychological testing; preclinical Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; VERBAL-LEARNING TEST; BRAIN; BETA; VALIDATION; BIOMARKERS; DEPOSITION; FEATURES; DECLINE;
D O I
10.1111/jnp.12332
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The pathophysiological development of Alzheimer's disease (AD) begins in the brain years before the onset of clinical symptoms. The accumulation of beta-amyloid (A ss) is thought to be the first cortical pathology to occur. Carrying one apolipoprotein E ( APOE) epsilon 4 allele increases the risk of developing AD at least 2-3 times and is associated with earlier A ss accumulation. Although it is difficult to identify A ss-related cognitive impairment in early AD with standard cognitive tests, more sensitive memory tests may be able to do this. We sought to examine associations between A ss and performance on three tests within three subdomains of memory, verbal, visual, and associative memory, to elucidate which of these tests were sensitive to A ss-related cognitive impairment in at-risk subjects. 55 APOE e4 carriers underwent MRI, C-11-Pittsburgh Compound B (PiB) PET, and cognitive testing. A composite cortical PiB SUVR cut-off score of 1.5 was used to categorise subjects as either APOE epsilon 4 A ss+ or APOE epsilon 4 A ss-. Correlations were carried out using cortical surface analysis. In the whole APOE epsilon 4 group, we found significant correlations between A ss load and performance on verbal, visual, and associative memory tests in widespread cortical areas, the strongest association being with performance on associative memory tests. In the APOE epsilon 4 A ss+ group, we found significant correlations between A ss load and performance of verbal and associative, but not visual, memory in localised cortical areas. Performance on verbal and associative memory tests provides sensitive markers of early A ss-related cognitive impairment in at-risk subjects.
引用
收藏
页码:120 / 135
页数:16
相关论文
共 50 条
  • [21] Amyloid Associated Proteins in Alzheimer's and Prion Disease
    Veerhuis, R.
    Boshuizen, R. S.
    Familian, A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2005, 4 (03) : 235 - 248
  • [22] Alzheimer's disease risk: amyloid versus neurodegeneration
    Bischof, Gerard N.
    LANCET NEUROLOGY, 2016, 15 (10): : 1000 - 1001
  • [23] VEGF genetic variability is associated with increased risk of developing Alzheimer's disease
    Del Bo, Roberto
    Ghezzi, Serena
    Scarpini, Elio
    Bresolin, Nereo
    Comi, Giacomo Pietro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 66 - 68
  • [24] A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease
    Lambert, JC
    Pasquier, F
    Cottel, D
    Frigard, B
    Amouyel, P
    Chartier-Harlin, MC
    HUMAN MOLECULAR GENETICS, 1998, 7 (03) : 533 - 540
  • [25] Effects of Synaptic Modulation on β-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice
    Tampellini, Davide
    Capetillo-Zarate, Estibaliz
    Dumont, Magali
    Huang, Zhenyong
    Yu, Fangmin
    Lin, Michael T.
    Gouras, Gunnar K.
    JOURNAL OF NEUROSCIENCE, 2010, 30 (43): : 14299 - 14304
  • [26] Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score
    Tomassen, Jori
    den Braber, Anouk
    van der Lee, Sven J.
    Reus, Lianne M.
    Konijnenberg, Elles
    Carter, Stephen F.
    Yaqub, Maqsood
    van Berckel, Bart N. M.
    Collij, Lyduine E.
    Boomsma, Dorret I.
    de Geus, Eco J. C.
    Scheltens, Philip
    Herholz, Karl
    Tijms, Betty M.
    Visser, Pieter Jelle
    BMC NEUROLOGY, 2022, 22 (01)
  • [27] Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's disease
    Penner, Gregory
    Lecocq, Soizic
    Chopin, Anaelle
    Vedoya, Ximena
    Lista, Simone
    Vergallo, Andrea
    Cavedo, Enrica
    Lejeune, Francois-Xavier
    Dubois, Bruno
    Hampel, Harald
    PLOS ONE, 2021, 16 (01):
  • [28] Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
    Jori Tomassen
    Anouk den Braber
    Sven J. van der Lee
    Lianne M. Reus
    Elles Konijnenberg
    Stephen F. Carter
    Maqsood Yaqub
    Bart N.M. van Berckel
    Lyduine E. Collij
    Dorret I. Boomsma
    Eco J.C. de Geus
    Philip Scheltens
    Karl Herholz
    Betty M. Tijms
    Pieter Jelle Visser
    BMC Neurology, 22
  • [29] Memory function associated with Alzheimer's disease susceptibility in relation to genetic risk
    Moore, P
    Owen, M
    Williams, J
    NEUROBIOLOGY OF AGING, 2004, 25 : S392 - S392
  • [30] Is KIBRA polymorphism associated with memory performance and cognitive impairment in Alzheimer's disease?
    Jurasova, Vanesa
    Andel, Ross
    Katonova, Alzbeta
    Nolan, Raena
    Lacinova, Zuzana
    Kolarova, Tereza
    Matoska, Vaclav
    Vyhnalek, Martin
    Hort, Jakub
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (01) : 218 - 227